<article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">PLoS One</journal-id>
      <journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id>
      <journal-id journal-id-type="publisher-id">plos</journal-id>
      <journal-id journal-id-type="pmc">plosone</journal-id>
      <journal-title-group>
        <journal-title>PLoS ONE</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1932-6203</issn>
      <publisher>
        <publisher-name>Public Library of Science</publisher-name>
        <publisher-loc>San Francisco, CA USA</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25822249</article-id>
      <article-id pub-id-type="pmc">4378850</article-id>
      <article-id pub-id-type="doi">10.1371/journal.pone.0120452</article-id>
      <article-id pub-id-type="publisher-id">PONE-D-14-43454</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Declining Incidence of Candidemia and the Shifting Epidemiology of <italic>Candida</italic> Resistance in Two US Metropolitan Areas, 2008–2013: Results from Population-Based Surveillance</article-title>
        <alt-title alt-title-type="running-head">Declining Incidence of Candidemia</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Cleveland</surname>
            <given-names>Angela Ahlquist</given-names>
          </name>
          <xref ref-type="aff" rid="aff001">
            <sup>1</sup>
          </xref>
          <xref rid="cor001" ref-type="corresp">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Harrison</surname>
            <given-names>Lee H.</given-names>
          </name>
          <xref ref-type="aff" rid="aff002">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Farley</surname>
            <given-names>Monica M.</given-names>
          </name>
          <xref ref-type="aff" rid="aff003">
            <sup>3</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hollick</surname>
            <given-names>Rosemary</given-names>
          </name>
          <xref ref-type="aff" rid="aff002">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Stein</surname>
            <given-names>Betsy</given-names>
          </name>
          <xref ref-type="aff" rid="aff003">
            <sup>3</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chiller</surname>
            <given-names>Tom M.</given-names>
          </name>
          <xref ref-type="aff" rid="aff001">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lockhart</surname>
            <given-names>Shawn R.</given-names>
          </name>
          <xref ref-type="aff" rid="aff001">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Park</surname>
            <given-names>Benjamin J.</given-names>
          </name>
          <xref ref-type="aff" rid="aff001">
            <sup>1</sup>
          </xref>
        </contrib>
      </contrib-group>
      <aff id="aff001">
        <label>1</label>
        <addr-line>Mycotic Diseases Branch, Division of Foodborne, Waterborne and Environmental Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America</addr-line>
      </aff>
      <aff id="aff002">
        <label>2</label>
        <addr-line>Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America</addr-line>
      </aff>
      <aff id="aff003">
        <label>3</label>
        <addr-line>Georgia Emerging Infections Program, Atlanta Veterans Affairs Medical Center and Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, United States of America</addr-line>
      </aff>
      <contrib-group>
        <contrib contrib-type="editor">
          <name>
            <surname>Chowdhary</surname>
            <given-names>Anuradha</given-names>
          </name>
          <role>Academic Editor</role>
          <xref ref-type="aff" rid="edit1"/>
        </contrib>
      </contrib-group>
      <aff id="edit1">
        <addr-line>V.P.Chest Institute, INDIA</addr-line>
      </aff>
      <author-notes>
        <fn fn-type="conflict" id="coi001">
          <p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p>
        </fn>
        <fn fn-type="con" id="contrib001">
          <p>Conceived and designed the experiments: AAC LHH MMF RH BS TMC SRL BJP. Performed the experiments: AAC LHH MMF RH BS TMC SRL BJP. Analyzed the data: AAC SRL BJP. Contributed reagents/materials/analysis tools: AAC LHH MMF RH BS TMC SRL BJP. Wrote the paper: AAC LHH MMF SRL BJP.</p>
        </fn>
        <corresp id="cor001">* E-mail: <email>ara0@cdc.gov</email></corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>30</day>
        <month>3</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2015</year>
      </pub-date>
      <volume>10</volume>
      <issue>3</issue>
      <elocation-id>e0120452</elocation-id>
      <history>
        <date date-type="received">
          <day>14</day>
          <month>10</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>22</day>
          <month>1</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <license xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">
          <license-p>This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">Creative Commons CC0</ext-link> public domain dedication</license-p>
        </license>
      </permissions>
      <self-uri content-type="pdf" xlink:type="simple" xlink:href="pone.0120452.pdf"/>
      <abstract>
        <sec id="sec001">
          <title>Background</title>
          <p>Recent reports have demonstrated a decline in bacterial bloodstream infections (BSIs) following adherence to central line insertion practices; however, declines have been less evident for BSIs due to <italic>Candida</italic> species.</p>
        </sec>
        <sec id="sec002">
          <title>Methods</title>
          <p>We conducted active, population-based laboratory surveillance for candidemia in metropolitan Atlanta, GA and Baltimore, MD over a 5-year period. We calculated annual candidemia incidence and antifungal drug resistance rates.</p>
        </sec>
        <sec id="sec003">
          <title>Results</title>
          <p>We identified 3,848 candidemia cases from 2008–2013. Compared with 2008, candidemia incidence per 100,000 person-years decreased significantly by 2013 in both locations (GA: 14.1 to 9.5, p&lt;0.001; MD: 30.9 to 14.4, p&lt;0.001). A total of 3,255 cases (85%) had a central venous catheter (CVC) in place within 2 days before the BSI culture date. In both locations, the number of CVC-associated cases declined (GA: 473 to 294; MD: 384 to 151). <italic>Candida albicans</italic> (CA, 36%) and <italic>Candida glabrata</italic> (CG, 27%) were the most common species recovered. In both locations, the proportion of cases with fluconazole resistance decreased (GA: 8.0% to 7.1%, −10%; MD: 6.6% to 4.9%, −25%), while the proportion of cases with an isolate resistant to an echinocandin increased (GA: 1.2% to 2.9%, +147%; MD: 2.0% to 3.5%, +77%). Most (74%) echinocandin-resistant isolates were CG; 17 (&lt;1%) isolates were resistant to both drug categories (multidrug resistant [MDR], 16/17 were CG). The proportion of CG cases with MDR <italic>Candida</italic> increased from 1.8% to 2.6%.</p>
        </sec>
        <sec id="sec004">
          <title>Conclusions</title>
          <p>We observed a significant decline in the incidence of candidemia over a five-year period, and increases in echinocandin-resistant and MDR <italic>Candida</italic>. Efforts to strengthen infection control practices may be preventing candidemia among high-risk patients. Further surveillance for resistant <italic>Candida</italic> is warranted.</p>
        </sec>
      </abstract>
      <funding-group>
        <funding-statement>The authors received no specific funding for this work.</funding-statement>
      </funding-group>
      <counts>
        <fig-count count="5"/>
        <table-count count="2"/>
        <page-count count="12"/>
      </counts>
      <custom-meta-group>
        <custom-meta id="data-availability">
          <meta-name>Data Availability</meta-name>
          <meta-value>All relevant data are within the paper.</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro" id="sec005">
      <title>Introduction</title>
      <p>Many healthcare-associated infections (HAIs), including some types of bloodstream infections (BSIs), are a preventable cause of morbidity and mortality in healthcare facilities. In an effort to reduce HAIs, the adoption of new healthcare policies, such as those tied to Medicare reimbursement, have incentivized reducing infection rates and produced mixed results [<xref rid="pone.0120452.ref001" ref-type="bibr">1</xref>–<xref rid="pone.0120452.ref006" ref-type="bibr">6</xref>].</p>
      <p>BSIs caused by <italic>Candida</italic> species, also known as candidemia, remain an important public health problem [<xref rid="pone.0120452.ref007" ref-type="bibr">7</xref>–<xref rid="pone.0120452.ref009" ref-type="bibr">9</xref>]. Recent reports have documented significant declines in some bacterial central line associated bloodstream infections (CLABSIs) following adherence to established central line insertion practices, however, similar declines have been less evident for CLABSIs due to <italic>Candida</italic> species [<xref rid="pone.0120452.ref010" ref-type="bibr">10</xref>–<xref rid="pone.0120452.ref014" ref-type="bibr">14</xref>]. <italic>Candida</italic> spp. are common gastrointestinal flora and while many <italic>Candida</italic> BSIs can be attributed to the presence of a central line, some <italic>Candida</italic> spp. are also hypothesized to cause infections by translocation across the gastrointestinal tract unrelated to central line insertion practices [<xref rid="pone.0120452.ref015" ref-type="bibr">15</xref>, <xref rid="pone.0120452.ref016" ref-type="bibr">16</xref>]. Therefore, line insertion bundles developed to reduce CLABSIs alone may not be completely effective in reducing <italic>Candida</italic> BSIs.</p>
      <p>In 2012, we reported a substantial increase over a twenty-year period in the overall population-based incidence of candidemia using population-based surveillance for candidemia in two U.S. locations [<xref rid="pone.0120452.ref009" ref-type="bibr">9</xref>, <xref rid="pone.0120452.ref017" ref-type="bibr">17</xref>]. This surveillance system captures all culture-confirmed BSIs caused by <italic>Candida</italic> spp., not just healthcare-associated CLABSIs that are tied to mandatory reporting and reimbursement policies, and provide a more complete picture of the burden of candidemia in these communities. The earlier report also noted a marked shift in the species distribution among causative organisms with a significant increase in <italic>Candida glabrata</italic> (CG), a species more likely to be resistant to azoles, the standard antifungal drug of choice.</p>
      <p>To monitor more recent changes in the incidence of candidemia and antifungal drug resistance, we now report trends over a five-year surveillance period using population-based prospective surveillance for candidemia in metropolitan Atlanta, Georgia and Baltimore City and County, Maryland.</p>
    </sec>
    <sec sec-type="methods" id="sec006">
      <title>Methods</title>
      <sec id="sec007">
        <title>Surveillance population</title>
        <p>Surveillance for candidemia was conducted among residents of Atlanta, Georgia (Fulton, DeKalb, Cobb, Gwinnett, Clayton, Douglas, Newton, and Rockdale counties; 25 hospitals, population: 3.8 million) and Baltimore City and County, Maryland (15 hospitals, population: 1.4 million). Data were collected for five years at each location (March 1, 2008—February 28, 2013 in Atlanta; June 1, 2008—May 31, 2013 in Baltimore).</p>
      </sec>
      <sec id="sec008">
        <title>Surveillance methods</title>
        <p>The methods of surveillance have been previously described [<xref rid="pone.0120452.ref009" ref-type="bibr">9</xref>]. Briefly, a case of candidemia was defined as a blood culture positive for a <italic>Candida</italic> species collected from a resident of the surveillance area at least 30 days apart from any other blood culture positive for <italic>Candida</italic> spp. Cases were classified as: (1) <italic>hospital-onset</italic> (HO) if the first culture was obtained &gt;3 days after admission (with admission being day 1), (2) <italic>healthcare-associated community-onset</italic> (HACO) if the culture was obtained ≤3 days after admission in a patient with recent healthcare exposure, or (3) <italic>community-associated</italic> (CA) if the culture was obtained as an outpatient or ≤3 days of admission in a patient without documentation of recent healthcare exposure. Basic demographic and clinical information was collected on all cases. Surveillance personnel used standardized case report forms to abstract data from medical records. Laboratory records from all participating laboratories were audited monthly.</p>
      </sec>
      <sec id="sec009">
        <title>Isolate collection, identification, and antifungal susceptibility testing</title>
        <p>All available isolates were sent to CDC for species confirmation and antifungal drug susceptibility testing; testing methods have been previously described [<xref rid="pone.0120452.ref018" ref-type="bibr">18</xref>]. CDC-confirmed species are reported; if no isolate was received at CDC, local laboratory species identifications are reported. Because in vitro susceptibility testing may demonstrate susceptibility to one echinocandin but resistance to another that is of questionable clinical correlation [<xref rid="pone.0120452.ref019" ref-type="bibr">19</xref>], molecular testing was used to confirm that the majority of the CG isolates with in vitro echinocandin resistance had a mutation that has been associated with clinical failure [<xref rid="pone.0120452.ref020" ref-type="bibr">20</xref>].</p>
      </sec>
      <sec id="sec010">
        <title>Statistical methods and denominators</title>
        <p>Incidence rates were calculated using year specific population estimates for Baltimore [<xref rid="pone.0120452.ref021" ref-type="bibr">21</xref>] and Atlanta [<xref rid="pone.0120452.ref022" ref-type="bibr">22</xref>] and are presented per 100,000 person-years. Age-adjusted incidence rates did not vary substantially over the five year surveillance period from crude rates, and thus we report crude annual incidence rates of candidemia.</p>
        <p>Categorical variables were analyzed using chi-square tests or Fisher’s exact tests. We used a Poisson regression model adjusting for age group to evaluate the change in overall and species specific annual incidence rates over the 5 year surveillance period. In all analyses, the level of significance was set at α = 0.05. All analyses were done using SAS software (version 9.3, SAS Institute, Inc., Cary, NC).</p>
      </sec>
      <sec id="sec011">
        <title>Human subjects</title>
        <p>Patient data were de-identified at each site prior to access and analysis by CDC. CDC conducted ethical review of this surveillance project and deemed it a non-research activity. This activity was also evaluated individually at each location, and was either deemed a public health assessment or human subjects research, and approved by local review boards. In the Baltimore area, the Maryland Department of Health and Mental Hygiene's Institutional Review Board reviewed and approved the protocol, and the protocol was determined exempt from review by the Johns Hopkins Bloomberg School of Public Health Institutional Review Board. In the Atlanta area, the protocol was reviewed and approved by the Emory University Institutional Review Board, and the protocol was determined exempt from review by the Georgia Department of Public Health Review Board.</p>
      </sec>
    </sec>
    <sec sec-type="results" id="sec012">
      <title>Results</title>
      <sec id="sec013">
        <title>Case-Patient Characteristics</title>
        <p>During the 5-year surveillance period, we detected 3,848 cases of candidemia: 2,324 (60%) in the Atlanta area (ATL) and 1,524 (40%) in Baltimore City and County (BTM, <xref rid="pone.0120452.t001" ref-type="table">Table 1</xref>). The median age was 58 years (range, 1 day—101 years), 1,992 (52%) were male, and 2,200 (60%) were black. <italic>Candida albicans</italic> (CA) was the most common species recovered (1,401 cases, 36%), followed by <italic>Candida glabrata</italic> (CG, 27%), <italic>Candida parapsilosis</italic> (CP, 15%), <italic>Candida tropicalis</italic> (CT, 9%), and other species (6%), and 6% of cases had &gt;1 species recovered from their initial blood culture. A total of 225 (7%) cases had an isolate that was resistant to fluconazole including 110/1049 (10%) CG. Fifty-five (2%) cases had an isolate that was resistant to an echinocandin including 43/1049 (4%) CG; 17 (&lt;1%) cases had an isolate that was multidrug resistant (MDR), defined as resistant to fluconazole and one or more echinocandins. Of the MDR cases, 16/17 (94%) were CG, representing 1.5% (16/1049) of CG isolates; 7/17 (44%) MDR cases occurred among persons without documented echinocandin exposure in the previous 14 days.</p>
        <table-wrap id="pone.0120452.t001" orientation="portrait" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0120452.t001</object-id>
          <label>Table 1</label>
          <caption>
            <title>Selected characteristics of patients with candidemia in Atlanta and Baltimore metropolitan areas.</title>
          </caption>
          <alternatives>
            <graphic id="pone.0120452.t001g" xlink:href="pone.0120452.t001"/>
            <table frame="hsides" rules="groups">
              <colgroup span="1">
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
              </colgroup>
              <thead>
                <tr>
                  <th align="left" rowspan="1" colspan="1"/>
                  <th align="left" rowspan="1" colspan="1"/>
                  <th colspan="2" align="center" rowspan="1">Atlanta</th>
                  <th colspan="2" align="center" rowspan="1">Baltimore</th>
                  <th colspan="2" align="center" rowspan="1">Total</th>
                </tr>
                <tr>
                  <th colspan="2" align="left" rowspan="1">Characteristic</th>
                  <th align="left" rowspan="1" colspan="1">n</th>
                  <th align="left" rowspan="1" colspan="1">(%)</th>
                  <th align="left" rowspan="1" colspan="1">n</th>
                  <th align="left" rowspan="1" colspan="1">(%)</th>
                  <th align="left" rowspan="1" colspan="1">n</th>
                  <th align="left" rowspan="1" colspan="1">(%)</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left" rowspan="1" colspan="1">
                    <bold>Cases</bold>
                  </td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">2324</td>
                  <td align="left" rowspan="1" colspan="1">(60)</td>
                  <td align="left" rowspan="1" colspan="1">1524</td>
                  <td align="left" rowspan="1" colspan="1">(40)</td>
                  <td align="left" rowspan="1" colspan="1">3848</td>
                  <td align="left" rowspan="1" colspan="1">(100)</td>
                </tr>
                <tr>
                  <td colspan="2" align="left" rowspan="1">
                    <bold>Median Age, years (range)</bold>
                  </td>
                  <td align="left" rowspan="1" colspan="1">58</td>
                  <td align="left" rowspan="1" colspan="1">(1 d-101 yrs)</td>
                  <td align="left" rowspan="1" colspan="1">58</td>
                  <td align="left" rowspan="1" colspan="1">(1 d-98 yrs)</td>
                  <td align="left" rowspan="1" colspan="1">58</td>
                  <td align="left" rowspan="1" colspan="1">(1 d-101 yrs)</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">
                    <bold>Male sex</bold>
                  </td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">1196</td>
                  <td align="left" rowspan="1" colspan="1">(52)</td>
                  <td align="left" rowspan="1" colspan="1">796</td>
                  <td align="left" rowspan="1" colspan="1">(52)</td>
                  <td align="left" rowspan="1" colspan="1">1992</td>
                  <td align="left" rowspan="1" colspan="1">(52)</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">
                    <bold>Black race</bold>
                  </td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">1427</td>
                  <td align="left" rowspan="1" colspan="1">(61)</td>
                  <td align="left" rowspan="1" colspan="1">873</td>
                  <td align="left" rowspan="1" colspan="1">(57)</td>
                  <td align="left" rowspan="1" colspan="1">2300</td>
                  <td align="left" rowspan="1" colspan="1">(57)</td>
                </tr>
                <tr>
                  <td colspan="8" align="left" rowspan="1">
                    <bold>CVC in place</bold>
                  </td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">All ages</td>
                  <td align="left" rowspan="1" colspan="1">1991</td>
                  <td align="left" rowspan="1" colspan="1">(86)</td>
                  <td align="left" rowspan="1" colspan="1">1264</td>
                  <td align="left" rowspan="1" colspan="1">(83)</td>
                  <td align="left" rowspan="1" colspan="1">3255</td>
                  <td align="left" rowspan="1" colspan="1">(85)</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">Age &lt;1 year</td>
                  <td align="left" rowspan="1" colspan="1">55</td>
                  <td align="left" rowspan="1" colspan="1">(72)</td>
                  <td align="left" rowspan="1" colspan="1">34</td>
                  <td align="left" rowspan="1" colspan="1">(92)</td>
                  <td align="left" rowspan="1" colspan="1">89</td>
                  <td align="left" rowspan="1" colspan="1">(79)</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">Age &gt; = 65</td>
                  <td align="left" rowspan="1" colspan="1">666</td>
                  <td align="left" rowspan="1" colspan="1">(80)</td>
                  <td align="left" rowspan="1" colspan="1">434</td>
                  <td align="left" rowspan="1" colspan="1">(76)</td>
                  <td align="left" rowspan="1" colspan="1">1100</td>
                  <td align="left" rowspan="1" colspan="1">(78)</td>
                </tr>
                <tr>
                  <td colspan="2" align="left" rowspan="1">
                    <bold>Resistance to fluconazole</bold>
                  </td>
                  <td align="left" rowspan="1" colspan="1">136</td>
                  <td align="left" rowspan="1" colspan="1">(07)</td>
                  <td align="left" rowspan="1" colspan="1">89</td>
                  <td align="left" rowspan="1" colspan="1">(06)</td>
                  <td align="left" rowspan="1" colspan="1">225</td>
                  <td align="left" rowspan="1" colspan="1">(07)</td>
                </tr>
                <tr>
                  <td colspan="2" align="left" rowspan="1">
                    <bold>Resistance to an echinocandin</bold>
                  </td>
                  <td align="left" rowspan="1" colspan="1">26</td>
                  <td align="left" rowspan="1" colspan="1">(01)</td>
                  <td align="left" rowspan="1" colspan="1">29</td>
                  <td align="left" rowspan="1" colspan="1">(02)</td>
                  <td align="left" rowspan="1" colspan="1">55</td>
                  <td align="left" rowspan="1" colspan="1">(02)</td>
                </tr>
                <tr>
                  <td colspan="2" align="left" rowspan="1">
                    <bold>Resistance to both flu and echino</bold>
                    <xref rid="t001fn001" ref-type="table-fn">*</xref>
                  </td>
                  <td align="left" rowspan="1" colspan="1">8</td>
                  <td align="left" rowspan="1" colspan="1">(&lt;1)</td>
                  <td align="left" rowspan="1" colspan="1">9</td>
                  <td align="left" rowspan="1" colspan="1">(&lt;1)</td>
                  <td align="left" rowspan="1" colspan="1">17<xref rid="t001fn001" ref-type="table-fn">*</xref></td>
                  <td align="left" rowspan="1" colspan="1">(&lt;1)</td>
                </tr>
                <tr>
                  <td colspan="8" align="left" rowspan="1">
                    <bold>Species</bold>
                  </td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"><italic>C</italic>. <italic>albicans</italic></td>
                  <td align="left" rowspan="1" colspan="1">921</td>
                  <td align="left" rowspan="1" colspan="1">(40)</td>
                  <td align="left" rowspan="1" colspan="1">480</td>
                  <td align="left" rowspan="1" colspan="1">(32)</td>
                  <td align="left" rowspan="1" colspan="1">1401</td>
                  <td align="left" rowspan="1" colspan="1">(36)</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"><italic>C</italic>. <italic>glabrata</italic></td>
                  <td align="left" rowspan="1" colspan="1">589</td>
                  <td align="left" rowspan="1" colspan="1">(25)</td>
                  <td align="left" rowspan="1" colspan="1">460</td>
                  <td align="left" rowspan="1" colspan="1">(30)</td>
                  <td align="left" rowspan="1" colspan="1">1049</td>
                  <td align="left" rowspan="1" colspan="1">(27)</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"><italic>C</italic>. <italic>parapsilosis</italic></td>
                  <td align="left" rowspan="1" colspan="1">390</td>
                  <td align="left" rowspan="1" colspan="1">(17)</td>
                  <td align="left" rowspan="1" colspan="1">204</td>
                  <td align="left" rowspan="1" colspan="1">(13)</td>
                  <td align="left" rowspan="1" colspan="1">594</td>
                  <td align="left" rowspan="1" colspan="1">(15)</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"><italic>C</italic>. <italic>tropicalis</italic></td>
                  <td align="left" rowspan="1" colspan="1">191</td>
                  <td align="left" rowspan="1" colspan="1">(08)</td>
                  <td align="left" rowspan="1" colspan="1">174</td>
                  <td align="left" rowspan="1" colspan="1">(11)</td>
                  <td align="left" rowspan="1" colspan="1">365</td>
                  <td align="left" rowspan="1" colspan="1">(09)</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"><italic>C</italic>. <italic>krusei</italic></td>
                  <td align="left" rowspan="1" colspan="1">38</td>
                  <td align="left" rowspan="1" colspan="1">(02)</td>
                  <td align="left" rowspan="1" colspan="1">15</td>
                  <td align="left" rowspan="1" colspan="1">(01)</td>
                  <td align="left" rowspan="1" colspan="1">53</td>
                  <td align="left" rowspan="1" colspan="1">(01)</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">
                    <italic>&gt;1 species</italic>
                  </td>
                  <td align="left" rowspan="1" colspan="1">100</td>
                  <td align="left" rowspan="1" colspan="1">(04)</td>
                  <td align="left" rowspan="1" colspan="1">110</td>
                  <td align="left" rowspan="1" colspan="1">(07)</td>
                  <td align="left" rowspan="1" colspan="1">210</td>
                  <td align="left" rowspan="1" colspan="1">(06)</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"><italic>C</italic>. <italic>dubliniensis</italic></td>
                  <td align="left" rowspan="1" colspan="1">16</td>
                  <td align="left" rowspan="1" colspan="1">(01)</td>
                  <td align="left" rowspan="1" colspan="1">41</td>
                  <td align="left" rowspan="1" colspan="1">(03)</td>
                  <td align="left" rowspan="1" colspan="1">57</td>
                  <td align="left" rowspan="1" colspan="1">(02)</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">
                    <italic>Other</italic>
                  </td>
                  <td align="left" rowspan="1" colspan="1">76</td>
                  <td align="left" rowspan="1" colspan="1">(03)</td>
                  <td align="left" rowspan="1" colspan="1">38</td>
                  <td align="left" rowspan="1" colspan="1">(03)</td>
                  <td align="left" rowspan="1" colspan="1">114</td>
                  <td align="left" rowspan="1" colspan="1">(03)</td>
                </tr>
                <tr>
                  <td colspan="8" align="left" rowspan="1">
                    <bold>Age groups, n (incidence rate per 100,000 person years)</bold>
                  </td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">&lt;1 year</td>
                  <td align="left" rowspan="1" colspan="1">76</td>
                  <td align="left" rowspan="1" colspan="1">(28.1)</td>
                  <td align="left" rowspan="1" colspan="1">37</td>
                  <td align="left" rowspan="1" colspan="1">(39.5)</td>
                  <td align="left" rowspan="1" colspan="1">113</td>
                  <td align="left" rowspan="1" colspan="1">(33.8)</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">1–19 years</td>
                  <td align="left" rowspan="1" colspan="1">88</td>
                  <td align="left" rowspan="1" colspan="1">(1.7)</td>
                  <td align="left" rowspan="1" colspan="1">33</td>
                  <td align="left" rowspan="1" colspan="1">(2.0)</td>
                  <td align="left" rowspan="1" colspan="1">121</td>
                  <td align="left" rowspan="1" colspan="1">(1.9)</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">20–44 years</td>
                  <td align="left" rowspan="1" colspan="1">429</td>
                  <td align="left" rowspan="1" colspan="1">(6.1)</td>
                  <td align="left" rowspan="1" colspan="1">298</td>
                  <td align="left" rowspan="1" colspan="1">(11.9)</td>
                  <td align="left" rowspan="1" colspan="1">727</td>
                  <td align="left" rowspan="1" colspan="1">(9.0)</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">45–64 years</td>
                  <td align="left" rowspan="1" colspan="1">899</td>
                  <td align="left" rowspan="1" colspan="1">(19.1)</td>
                  <td align="left" rowspan="1" colspan="1">574</td>
                  <td align="left" rowspan="1" colspan="1">(30.0)</td>
                  <td align="left" rowspan="1" colspan="1">1473</td>
                  <td align="left" rowspan="1" colspan="1">(24.6)</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">&gt; = 65 years</td>
                  <td align="left" rowspan="1" colspan="1">832</td>
                  <td align="left" rowspan="1" colspan="1">(51.2)</td>
                  <td align="left" rowspan="1" colspan="1">576</td>
                  <td align="left" rowspan="1" colspan="1">(60.1)</td>
                  <td align="left" rowspan="1" colspan="1">1408</td>
                  <td align="left" rowspan="1" colspan="1">(55.7)</td>
                </tr>
              </tbody>
            </table>
          </alternatives>
          <table-wrap-foot>
            <fn id="t001fn001">
              <p>*16/17 isolates were <italic>C</italic>. <italic>glabrata</italic> species</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec id="sec014">
        <title>Changes in Incidence Rates</title>
        <p>Crude annual incidence rates per 100,000 person-years are illustrated in <xref rid="pone.0120452.g001" ref-type="fig">Fig. 1</xref>. Compared with 2008 (year 1), the incidence of candidemia decreased significantly in both locations: in ATL, incidence rates declined 33% from 14.1/100,000 from the first year of surveillance to 9.5/100,000 by year 5 (<italic>p</italic>&lt;0.001). In BTM, incidence rates declined 54% from 30.9/100,000 from year 1 to 14.4/100,000 by year 5 (<italic>p</italic>&lt;0.001).</p>
        <fig id="pone.0120452.g001" orientation="portrait" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0120452.g001</object-id>
          <label>Fig 1</label>
          <caption>
            <title>Annual candidemia incidence rates per 100,000 person-years, by year and location, 2008–2013.</title>
          </caption>
          <graphic xlink:href="pone.0120452.g001"/>
        </fig>
        <p>Infants aged &lt;1 year and adults aged ≥65 years had the highest rates of candidemia out of all age groups (infants: 33.8/100,000; adults: 55.7/100,000; <xref rid="pone.0120452.t001" ref-type="table">Table 1</xref>). Analysis of age-specific incidence rates per 100,000 person-years demonstrated a decline in every age group except among persons aged 1–19 years in BTM, which increased 17% (from 2.0/100,000 in year 1 to 2.4/100,000 in year 5); all other age groups demonstrated a decline (<xref rid="pone.0120452.g002" ref-type="fig">Fig. 2</xref> and <xref rid="pone.0120452.g003" ref-type="fig">Fig. 3</xref>). In ATL, the decline was greatest for persons aged &lt;1 year (from 41.7 to 16.6, −60% decline), followed by persons aged ≥65 years (from 61.3 to 36.0, −41%,) and aged 45–64 years (from 21.7 to 15.1, −30%) (<xref rid="pone.0120452.g002" ref-type="fig">Fig. 2</xref>). In BTM, the decline was greatest for persons aged 20–44 years (from 19.7 to 6.6, −67%), followed by persons aged 45–64 years (from 42.7 to 19.6, −54%), ≥65 years (from 87.4 to 43.3, −50%) and &lt;1 year (from 51.9 to 32.0, −38%) (<xref rid="pone.0120452.g003" ref-type="fig">Fig. 3</xref>).</p>
        <fig id="pone.0120452.g002" orientation="portrait" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0120452.g002</object-id>
          <label>Fig 2</label>
          <caption>
            <title>Annual candidemia incidence rates per 100,000 person-years, by year and age-group in the Metropolitan Baltimore area.</title>
          </caption>
          <graphic xlink:href="pone.0120452.g002"/>
        </fig>
        <fig id="pone.0120452.g003" orientation="portrait" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0120452.g003</object-id>
          <label>Fig 3</label>
          <caption>
            <title>Annual candidemia incidence rates per 100,000 person-years, by year and age-group in the Metropolitan Atlanta area.</title>
          </caption>
          <graphic xlink:href="pone.0120452.g003"/>
        </fig>
      </sec>
      <sec id="sec015">
        <title>Hospital-specific Declines</title>
        <p>Among 40 hospitals under surveillance, 85% reported either a decrease or no change in the frequency of cases over the surveillance period (<xref rid="pone.0120452.g004" ref-type="fig">Fig. 4</xref>). Additionally, of the eight hospitals that contributed at least 100 cases during the 5 years of surveillance, there was a substantial drop in the number of cases identified: in ATL 319 cases were identified in the first year, and 190 were identified in the last year (−40%); in BTM, 282 cases were identified in the first year and 125 were identified in the last year (−56%).</p>
        <fig id="pone.0120452.g004" orientation="portrait" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0120452.g004</object-id>
          <label>Fig 4</label>
          <caption>
            <title>Changes in candidemia case count at participating hospitals over the five-year study period (2008–2013), by the total number of cases each hospital contributed during the study.</title>
          </caption>
          <graphic xlink:href="pone.0120452.g004"/>
        </fig>
      </sec>
      <sec id="sec016">
        <title>High Risk Groups</title>
        <p>In both locations, the frequency of hospital onset (HO) and healthcare-associated community onset (HACO) cases decreased, but community-associated (CA) did not: in ATL, HO cases declined from 405 in year 1 to 226 in year 5 (−44%), HACO declined from 124 to 111 (−10%), and CA changed from 12 to 14 (+17%);. In BTM, HO cases declined from 253 to 111 (−56%), HACO dropped from 175 to 79 (−55%), and CA changed from 12 to 15 (+25%) (<xref rid="pone.0120452.t002" ref-type="table">Table 2</xref>). Among the 135 CA cases, 58 (43%) had diabetes (49% in ATL; 35% in BTM).</p>
        <table-wrap id="pone.0120452.t002" orientation="portrait" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0120452.t002</object-id>
          <label>Table 2</label>
          <caption>
            <title>Selected characteristics of candidemia patients by year of surveillance, in Atlanta (ATL) and Baltimore (BTM) metropolitan areas.</title>
          </caption>
          <alternatives>
            <graphic id="pone.0120452.t002g" xlink:href="pone.0120452.t002"/>
            <table frame="hsides" rules="groups">
              <colgroup span="1">
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
                <col align="left" valign="middle" span="1"/>
              </colgroup>
              <thead>
                <tr>
                  <th colspan="2" align="center" rowspan="1">Characteristic</th>
                  <th align="left" rowspan="1" colspan="1">Y1</th>
                  <th align="left" rowspan="1" colspan="1">Y2</th>
                  <th align="left" rowspan="1" colspan="1">Y3</th>
                  <th align="left" rowspan="1" colspan="1">Y4</th>
                  <th align="left" rowspan="1" colspan="1">Y5</th>
                  <th align="left" rowspan="1" colspan="1">Change</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td colspan="8" align="left" rowspan="1">
                    <bold>Total Cases</bold>
                  </td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">
                    <bold>ATL</bold>
                  </td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">541</td>
                  <td align="left" rowspan="1" colspan="1">526</td>
                  <td align="left" rowspan="1" colspan="1">487</td>
                  <td align="left" rowspan="1" colspan="1">419</td>
                  <td align="left" rowspan="1" colspan="1">351</td>
                  <td align="left" rowspan="1" colspan="1">−35%</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">
                    <bold>BTM</bold>
                  </td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">440</td>
                  <td align="left" rowspan="1" colspan="1">354</td>
                  <td align="left" rowspan="1" colspan="1">323</td>
                  <td align="left" rowspan="1" colspan="1">202</td>
                  <td align="left" rowspan="1" colspan="1">205</td>
                  <td align="left" rowspan="1" colspan="1">−53%</td>
                </tr>
                <tr>
                  <td colspan="8" align="left" rowspan="1">
                    <bold>Crude Incidence Rate</bold>
                  </td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">
                    <bold>ATL</bold>
                  </td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">14.1</td>
                  <td align="left" rowspan="1" colspan="1">13.5</td>
                  <td align="left" rowspan="1" colspan="1">13.2</td>
                  <td align="left" rowspan="1" colspan="1">11.4</td>
                  <td align="left" rowspan="1" colspan="1">9.5</td>
                  <td align="left" rowspan="1" colspan="1">−33%</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">
                    <bold>BTM</bold>
                  </td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">30.9</td>
                  <td align="left" rowspan="1" colspan="1">24.8</td>
                  <td align="left" rowspan="1" colspan="1">22.7</td>
                  <td align="left" rowspan="1" colspan="1">14.2</td>
                  <td align="left" rowspan="1" colspan="1">14.4</td>
                  <td align="left" rowspan="1" colspan="1">−54%</td>
                </tr>
                <tr>
                  <td colspan="8" align="left" rowspan="1">
                    <bold>Patient group (n)</bold>
                  </td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">
                    <bold>ATL</bold>
                  </td>
                  <td align="left" rowspan="1" colspan="1">
                    <italic>HO</italic>
                  </td>
                  <td align="left" rowspan="1" colspan="1">405</td>
                  <td align="left" rowspan="1" colspan="1">374</td>
                  <td align="left" rowspan="1" colspan="1">335</td>
                  <td align="left" rowspan="1" colspan="1">270</td>
                  <td align="left" rowspan="1" colspan="1">226</td>
                  <td align="left" rowspan="1" colspan="1">−44%</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">
                    <italic>HACO</italic>
                  </td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">124</td>
                  <td align="left" rowspan="1" colspan="1">135</td>
                  <td align="left" rowspan="1" colspan="1">136</td>
                  <td align="left" rowspan="1" colspan="1">128</td>
                  <td align="left" rowspan="1" colspan="1">111</td>
                  <td align="left" rowspan="1" colspan="1">−10%</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">
                    <italic>CA</italic>
                  </td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">12</td>
                  <td align="left" rowspan="1" colspan="1">17</td>
                  <td align="left" rowspan="1" colspan="1">16</td>
                  <td align="left" rowspan="1" colspan="1">21</td>
                  <td align="left" rowspan="1" colspan="1">14</td>
                  <td align="left" rowspan="1" colspan="1">17%</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">
                    <bold>BTM</bold>
                  </td>
                  <td align="left" rowspan="1" colspan="1">
                    <italic>HO</italic>
                  </td>
                  <td align="left" rowspan="1" colspan="1">253</td>
                  <td align="left" rowspan="1" colspan="1">223</td>
                  <td align="left" rowspan="1" colspan="1">182</td>
                  <td align="left" rowspan="1" colspan="1">121</td>
                  <td align="left" rowspan="1" colspan="1">111</td>
                  <td align="left" rowspan="1" colspan="1">−56%</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">
                    <italic>HACO</italic>
                  </td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">175</td>
                  <td align="left" rowspan="1" colspan="1">122</td>
                  <td align="left" rowspan="1" colspan="1">131</td>
                  <td align="left" rowspan="1" colspan="1">72</td>
                  <td align="left" rowspan="1" colspan="1">79</td>
                  <td align="left" rowspan="1" colspan="1">−55%</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">
                    <italic>CA</italic>
                  </td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">12</td>
                  <td align="left" rowspan="1" colspan="1">9</td>
                  <td align="left" rowspan="1" colspan="1">10</td>
                  <td align="left" rowspan="1" colspan="1">9</td>
                  <td align="left" rowspan="1" colspan="1">15</td>
                  <td align="left" rowspan="1" colspan="1">25%</td>
                </tr>
                <tr>
                  <td colspan="8" align="left" rowspan="1">
                    <bold>Central Venous Catheter within 2 days of candidemia (n)</bold>
                  </td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">
                    <bold>ATL</bold>
                  </td>
                  <td align="left" rowspan="1" colspan="1">
                    <italic>All ages</italic>
                  </td>
                  <td align="left" rowspan="1" colspan="1">473</td>
                  <td align="left" rowspan="1" colspan="1">454</td>
                  <td align="left" rowspan="1" colspan="1">421</td>
                  <td align="left" rowspan="1" colspan="1">349</td>
                  <td align="left" rowspan="1" colspan="1">294</td>
                  <td align="left" rowspan="1" colspan="1">−38%</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">
                    <italic>&lt;1 year of age</italic>
                  </td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">14</td>
                  <td align="left" rowspan="1" colspan="1">22</td>
                  <td align="left" rowspan="1" colspan="1">6</td>
                  <td align="left" rowspan="1" colspan="1">4</td>
                  <td align="left" rowspan="1" colspan="1">9</td>
                  <td align="left" rowspan="1" colspan="1">−36%</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">
                    <italic>&gt; = 65 years of age</italic>
                  </td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">159</td>
                  <td align="left" rowspan="1" colspan="1">138</td>
                  <td align="left" rowspan="1" colspan="1">158</td>
                  <td align="left" rowspan="1" colspan="1">118</td>
                  <td align="left" rowspan="1" colspan="1">93</td>
                  <td align="left" rowspan="1" colspan="1">−42%</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">
                    <bold>BTM</bold>
                  </td>
                  <td align="left" rowspan="1" colspan="1">
                    <italic>All ages</italic>
                  </td>
                  <td align="left" rowspan="1" colspan="1">384</td>
                  <td align="left" rowspan="1" colspan="1">312</td>
                  <td align="left" rowspan="1" colspan="1">262</td>
                  <td align="left" rowspan="1" colspan="1">155</td>
                  <td align="left" rowspan="1" colspan="1">151</td>
                  <td align="left" rowspan="1" colspan="1">−61%</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">
                    <italic>&lt;1 year of age</italic>
                  </td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">10</td>
                  <td align="left" rowspan="1" colspan="1">9</td>
                  <td align="left" rowspan="1" colspan="1">6</td>
                  <td align="left" rowspan="1" colspan="1">3</td>
                  <td align="left" rowspan="1" colspan="1">6</td>
                  <td align="left" rowspan="1" colspan="1">−40%</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">
                    <italic>&gt; = 65 years of age</italic>
                  </td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">136</td>
                  <td align="left" rowspan="1" colspan="1">114</td>
                  <td align="left" rowspan="1" colspan="1">77</td>
                  <td align="left" rowspan="1" colspan="1">58</td>
                  <td align="left" rowspan="1" colspan="1">49</td>
                  <td align="left" rowspan="1" colspan="1">−64%</td>
                </tr>
                <tr>
                  <td colspan="8" align="left" rowspan="1">
                    <bold>Surgery among patients who did not have a CVC (n)</bold>
                  </td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">
                    <bold>ATL</bold>
                  </td>
                  <td align="left" rowspan="1" colspan="1">
                    <italic>Ab surgery</italic>
                  </td>
                  <td align="left" rowspan="1" colspan="1">11</td>
                  <td align="left" rowspan="1" colspan="1">6</td>
                  <td align="left" rowspan="1" colspan="1">6</td>
                  <td align="left" rowspan="1" colspan="1">9</td>
                  <td align="left" rowspan="1" colspan="1">6</td>
                  <td align="left" rowspan="1" colspan="1">−45%</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">
                    <italic>Non ab surgery</italic>
                  </td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">7</td>
                  <td align="left" rowspan="1" colspan="1">4</td>
                  <td align="left" rowspan="1" colspan="1">6</td>
                  <td align="left" rowspan="1" colspan="1">6</td>
                  <td align="left" rowspan="1" colspan="1">7</td>
                  <td align="left" rowspan="1" colspan="1">0%</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">
                    <bold>BTM</bold>
                  </td>
                  <td align="left" rowspan="1" colspan="1">
                    <italic>Ab surgery</italic>
                  </td>
                  <td align="left" rowspan="1" colspan="1">6</td>
                  <td align="left" rowspan="1" colspan="1">11</td>
                  <td align="left" rowspan="1" colspan="1">10</td>
                  <td align="left" rowspan="1" colspan="1">6</td>
                  <td align="left" rowspan="1" colspan="1">6</td>
                  <td align="left" rowspan="1" colspan="1">0%</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">
                    <italic>Non ab surgery</italic>
                  </td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">7</td>
                  <td align="left" rowspan="1" colspan="1">5</td>
                  <td align="left" rowspan="1" colspan="1">3</td>
                  <td align="left" rowspan="1" colspan="1">5</td>
                  <td align="left" rowspan="1" colspan="1">7</td>
                  <td align="left" rowspan="1" colspan="1">0%</td>
                </tr>
                <tr>
                  <td colspan="8" align="left" rowspan="1">
                    <bold>Species-Specific Incidence Rates (IR)</bold>
                  </td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">
                    <bold>ATL</bold>
                  </td>
                  <td align="left" rowspan="1" colspan="1">
                    <italic>CA</italic>
                  </td>
                  <td align="left" rowspan="1" colspan="1">5.91</td>
                  <td align="left" rowspan="1" colspan="1">5.73</td>
                  <td align="left" rowspan="1" colspan="1">5.59</td>
                  <td align="left" rowspan="1" colspan="1">4.86</td>
                  <td align="left" rowspan="1" colspan="1">3.72</td>
                  <td align="left" rowspan="1" colspan="1">−37%</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">
                    <italic>CG</italic>
                  </td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">4.28</td>
                  <td align="left" rowspan="1" colspan="1">3.62</td>
                  <td align="left" rowspan="1" colspan="1">3.35</td>
                  <td align="left" rowspan="1" colspan="1">2.72</td>
                  <td align="left" rowspan="1" colspan="1">2.86</td>
                  <td align="left" rowspan="1" colspan="1">−33%</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">
                    <italic>CP</italic>
                  </td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">2.38</td>
                  <td align="left" rowspan="1" colspan="1">2.62</td>
                  <td align="left" rowspan="1" colspan="1">2.39</td>
                  <td align="left" rowspan="1" colspan="1">2.25</td>
                  <td align="left" rowspan="1" colspan="1">1.63</td>
                  <td align="left" rowspan="1" colspan="1">−31%</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">
                    <italic>CT</italic>
                  </td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">0.71</td>
                  <td align="left" rowspan="1" colspan="1">0.80</td>
                  <td align="left" rowspan="1" colspan="1">1.22</td>
                  <td align="left" rowspan="1" colspan="1">0.90</td>
                  <td align="left" rowspan="1" colspan="1">0.73</td>
                  <td align="left" rowspan="1" colspan="1">4%</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">
                    <italic>CK</italic>
                  </td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">0.27</td>
                  <td align="left" rowspan="1" colspan="1">0.26</td>
                  <td align="left" rowspan="1" colspan="1">0.19</td>
                  <td align="left" rowspan="1" colspan="1">0.19</td>
                  <td align="left" rowspan="1" colspan="1">0.25</td>
                  <td align="left" rowspan="1" colspan="1">−8%</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">
                    <italic>Other</italic>
                  </td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">0.42</td>
                  <td align="left" rowspan="1" colspan="1">0.54</td>
                  <td align="left" rowspan="1" colspan="1">0.70</td>
                  <td align="left" rowspan="1" colspan="1">0.38</td>
                  <td align="left" rowspan="1" colspan="1">0.46</td>
                  <td align="left" rowspan="1" colspan="1">8%</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">
                    <bold>BTM</bold>
                  </td>
                  <td align="left" rowspan="1" colspan="1">
                    <italic>CA</italic>
                  </td>
                  <td align="left" rowspan="1" colspan="1">11.60</td>
                  <td align="left" rowspan="1" colspan="1">9.18</td>
                  <td align="left" rowspan="1" colspan="1">7.72</td>
                  <td align="left" rowspan="1" colspan="1">4.56</td>
                  <td align="left" rowspan="1" colspan="1">5.12</td>
                  <td align="left" rowspan="1" colspan="1">−56%</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">
                    <italic>CG</italic>
                  </td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">9.34</td>
                  <td align="left" rowspan="1" colspan="1">8.14</td>
                  <td align="left" rowspan="1" colspan="1">8.20</td>
                  <td align="left" rowspan="1" colspan="1">5.68</td>
                  <td align="left" rowspan="1" colspan="1">4.97</td>
                  <td align="left" rowspan="1" colspan="1">−47%</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">
                    <italic>CP</italic>
                  </td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">5.41</td>
                  <td align="left" rowspan="1" colspan="1">4.07</td>
                  <td align="left" rowspan="1" colspan="1">3.51</td>
                  <td align="left" rowspan="1" colspan="1">1.69</td>
                  <td align="left" rowspan="1" colspan="1">1.47</td>
                  <td align="left" rowspan="1" colspan="1">−73%</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">
                    <italic>CT</italic>
                  </td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">3.53</td>
                  <td align="left" rowspan="1" colspan="1">3.03</td>
                  <td align="left" rowspan="1" colspan="1">3.15</td>
                  <td align="left" rowspan="1" colspan="1">1.33</td>
                  <td align="left" rowspan="1" colspan="1">1.97</td>
                  <td align="left" rowspan="1" colspan="1">−44%</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">
                    <italic>CK</italic>
                  </td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">0.43</td>
                  <td align="left" rowspan="1" colspan="1">0.37</td>
                  <td align="left" rowspan="1" colspan="1">0.14</td>
                  <td align="left" rowspan="1" colspan="1">0.14</td>
                  <td align="left" rowspan="1" colspan="1">0.28</td>
                  <td align="left" rowspan="1" colspan="1">−35%</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">
                    <italic>Other</italic>
                  </td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">0.93</td>
                  <td align="left" rowspan="1" colspan="1">0.99</td>
                  <td align="left" rowspan="1" colspan="1">1.20</td>
                  <td align="left" rowspan="1" colspan="1">0.47</td>
                  <td align="left" rowspan="1" colspan="1">0.69</td>
                  <td align="left" rowspan="1" colspan="1">−26%</td>
                </tr>
                <tr>
                  <td colspan="8" align="left" rowspan="1">
                    <bold>% Resistant to Fluconazole</bold>
                  </td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">
                    <italic>ATL</italic>
                  </td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">8%</td>
                  <td align="left" rowspan="1" colspan="1">9.38%</td>
                  <td align="left" rowspan="1" colspan="1">5.67%</td>
                  <td align="left" rowspan="1" colspan="1">7%</td>
                  <td align="left" rowspan="1" colspan="1">7.14%</td>
                  <td align="left" rowspan="1" colspan="1">−10%</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">
                    <italic>BTM</italic>
                  </td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">6.57%</td>
                  <td align="left" rowspan="1" colspan="1">8.07%</td>
                  <td align="left" rowspan="1" colspan="1">4.73%</td>
                  <td align="left" rowspan="1" colspan="1">4.50%</td>
                  <td align="left" rowspan="1" colspan="1">4.93%</td>
                  <td align="left" rowspan="1" colspan="1">−25%</td>
                </tr>
                <tr>
                  <td colspan="8" align="left" rowspan="1">
                    <bold>% Resistant to an Echinocandin</bold>
                  </td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">
                    <italic>ATL</italic>
                  </td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">1.18%</td>
                  <td align="left" rowspan="1" colspan="1">1.44%</td>
                  <td align="left" rowspan="1" colspan="1">0.99%</td>
                  <td align="left" rowspan="1" colspan="1">0.83%</td>
                  <td align="left" rowspan="1" colspan="1">2.92%</td>
                  <td align="left" rowspan="1" colspan="1">147%</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">
                    <italic>BTM</italic>
                  </td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">1.95%</td>
                  <td align="left" rowspan="1" colspan="1">0.58%</td>
                  <td align="left" rowspan="1" colspan="1">2.21%</td>
                  <td align="left" rowspan="1" colspan="1">2.50%</td>
                  <td align="left" rowspan="1" colspan="1">3.45%</td>
                  <td align="left" rowspan="1" colspan="1">77%</td>
                </tr>
                <tr>
                  <td colspan="8" align="left" rowspan="1">
                    <bold>% Multidrug Resistant Candida</bold>
                  </td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">
                    <italic>ATL</italic>
                  </td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">0.18%</td>
                  <td align="left" rowspan="1" colspan="1">0.38%</td>
                  <td align="left" rowspan="1" colspan="1">0%</td>
                  <td align="left" rowspan="1" colspan="1">0.48%</td>
                  <td align="left" rowspan="1" colspan="1">0.85%</td>
                  <td align="left" rowspan="1" colspan="1">372%</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">
                    <italic>BTM</italic>
                  </td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1">0.91%</td>
                  <td align="left" rowspan="1" colspan="1">0%</td>
                  <td align="left" rowspan="1" colspan="1">0.62%</td>
                  <td align="left" rowspan="1" colspan="1">0.50%</td>
                  <td align="left" rowspan="1" colspan="1">0.98%</td>
                  <td align="left" rowspan="1" colspan="1">8%</td>
                </tr>
              </tbody>
            </table>
          </alternatives>
          <table-wrap-foot>
            <fn id="t002fn001">
              <p><bold><italic>Note</italic>:</bold>
<italic>HO</italic>, <italic>healthcare onset</italic>. <italic>HACO</italic>, <italic>healthcare-associated community-onset</italic>. <italic>CA</italic>, <italic>community-acquired</italic>. <italic>Ab surgery</italic>, <italic>abdominal surgery</italic>. <italic>Y</italic>, <italic>year</italic>.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p>A total of 3,255 cases (85%) had a central venous catheter (CVC) in place within 2 days prior to the date of their initial culture positive for <italic>Candida</italic> spp. (<xref rid="pone.0120452.t001" ref-type="table">Table 1</xref>). In ATL, CVC-associated cases (n = 1,991) declined from 473 (87%) in year 1 to 294 (84%) in year 5 (−38%) (<italic>p</italic> = 0.030); in BTM, the number of cases with a CVC declined from 384 (87%) to 151 (74%) (−61%) (<italic>p</italic>&lt;0.001) (<xref rid="pone.0120452.g005" ref-type="fig">Fig. 5</xref>). The number of non-CVC-associated cases declined in ATL from 68 (13%) to 57 (16%); and in BTM from 56 (13%) to 53 (26%).</p>
        <fig id="pone.0120452.g005" orientation="portrait" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0120452.g005</object-id>
          <label>Fig 5</label>
          <caption>
            <title>Candidemia cases that had a CVC compared with cases that had no CVC, in Atlanta (ATL) and Baltimore (BTM), 2008–2013.</title>
          </caption>
          <graphic xlink:href="pone.0120452.g005"/>
        </fig>
      </sec>
      <sec id="sec017">
        <title>Changes in species distribution</title>
        <p>Species-specific incidence rates of all species decreased from year 1 to year 5 in both locations except for CT in ATL, which increased 4% (from 0.71/100,000 to 0.73/100,000, <xref rid="pone.0120452.t002" ref-type="table">Table 2</xref>). In ATL, CA had the largest drop in incidence (from 5.91/100,000 in year 1 to 3.72/100,000 in year 5, −37%), followed by CG (from 4.28 to 2.86, −33%), and CP (from 2.38 to 1.63, −31%). In BTM, CP had the greatest drop in incidence (from 5.41 to 1.47, −73%), followed by CA (from 11.6 to 5.12, −56%), and CG (from 9.34 to 4.97, −47%).</p>
      </sec>
      <sec id="sec018">
        <title>Change in antifungal drug resistance</title>
        <p>In both locations, the overall percent of cases with an isolate resistant to fluconazole decreased (ATL: from 8.0% to 7.1%, −10%; BTM: from 6.6% to 4.9%, −25%), while the overall percent of cases with an isolate resistant to an echinocandin increased (ATL: from 1.2% to 2.9%, +147%; BTM: from 2.0% to 3.5%, +77%; <xref rid="pone.0120452.t002" ref-type="table">Table 2</xref>); 41 (75%) isolates resistant to an echinocandin were CG; other echinocandin-resistant species included CA (n = 7), CT (n = 3), CP (n = 2), and CD (n = 1). The proportion of CG cases due to multi-drug resistant (MDR) <italic>Candida</italic>, increased from 1.8% in 2008 to 2.6% in 2013.</p>
      </sec>
    </sec>
    <sec sec-type="conclusions" id="sec019">
      <title>Discussion</title>
      <p>This report from the largest U.S. population-based surveillance program for candidemia to date describes a significant decline in the overall incidence of candidemia in two metropolitan regions. This decline was seen in almost all age groups, was primarily among patients with healthcare exposure, and was especially notable among cases with a central venous catheter. Importantly, we also report an increase in echinocandin resistance as well as the emergence of multi-drug resistant <italic>Candida</italic> BSIs.</p>
      <p>In 2012, we reported an increase in candidemia incidence over a twenty year period, as seen through two periodic measurements using population-based surveillance [<xref rid="pone.0120452.ref009" ref-type="bibr">9</xref>], that was attributed to multifactorial changes in patient populations, including possible increases in patient populations at high risk for candidemia.</p>
      <p>In comparison, our current report documents a subsequent decrease in incidence that is not likely to be due to changes in high-risk populations; rather, it is probable that the declines noted here are related to healthcare delivery improvements. We found that declines were predominantly among candidemia cases with healthcare exposure, but not among the small number of community-associated cases, suggesting that factors associated with healthcare delivery may be driving this decline. Our data further demonstrate declines among patients with <italic>Candida</italic> BSIs occurring in the presence of CVCs, while the number of cases without CVCs did not decline as substantially. Taken together, these data suggest that the large declines noted here may be the result of policies and practices related to catheter insertion and maintenance.</p>
      <p>Recent policies targeted at reducing healthcare-associated infections, including state mandates for public reporting, have incentivized reducing CLABSIs [<xref rid="pone.0120452.ref001" ref-type="bibr">1</xref>]. Subsequent reports including data from CDC’s National Health Safety Network (NHSN) have described large declines in CLABSI rates [<xref rid="pone.0120452.ref013" ref-type="bibr">13</xref>, <xref rid="pone.0120452.ref023" ref-type="bibr">23</xref>, <xref rid="pone.0120452.ref024" ref-type="bibr">24</xref>]. Data from our active surveillance system, which is not tied to any reimbursement or reporting mechanism, support the trends observed through systems such as NHSN and suggest these declines are robust. Anecdotally, most hospitals in our surveillance area have recently introduced policies that mandate improvements in catheter care (data not shown); further study is needed to understand if declines can be attributed to these policies.</p>
      <p>Notably, while we documented a drop in fluconazole resistance, we also report a small but concerning increase in isolates resistant to echinocandins, and the emergence of multidrug resistant (MDR) <italic>Candida</italic>, almost all of which were the species CG. Although the decrease in fluconazole resistance is reassuring, it may be partially due to the increased use of echinocandins as primary therapy for candidemia. This shift in practice, particularly for CG infections, may be contributing to the increase in echinocandin resistance; recent reports have demonstrated the emergence of echinocandin resistant CG[<xref rid="pone.0120452.ref017" ref-type="bibr">17</xref>, <xref rid="pone.0120452.ref025" ref-type="bibr">25</xref>, <xref rid="pone.0120452.ref026" ref-type="bibr">26</xref>], possibly driven by wider usage of this drug class as primary therapy[<xref rid="pone.0120452.ref027" ref-type="bibr">27</xref>] and prophylaxis. Although the modes of action and target sites of the triazoles (i.e. fluconazole) and echinocandins are different[<xref rid="pone.0120452.ref028" ref-type="bibr">28</xref>], CG are the most common fluconazole-resistant species, and mutations conferring echinocandin resistance in CG can emerge quickly[<xref rid="pone.0120452.ref029" ref-type="bibr">29</xref>]. Microbiology laboratories should consider antifungal susceptibility testing for CG isolates, since detection of echinocandin-resistant or MDR <italic>Candida</italic> can influence therapy.</p>
      <p>It is also concerning that 44% of MDR <italic>Candida</italic> occurred in patients without recent exposure to echinocandins. This observation suggests person-to-person transmission of this resistant phenotype is possible, as has been previously suggested [<xref rid="pone.0120452.ref030" ref-type="bibr">30</xref>]. Vigilant monitoring for resistance among CG species will continue to be critical, and further investigation into the possible transmission of MDR <italic>Candida</italic> will be essential for targeting prevention efforts.</p>
      <p>This report is subject to several limitations. Although we suspect that the dramatic declines in candidemia occurring in patients with a CVC were due to improved catheter care, it is possible that declines were due to some external factor such as reductions in overall CVC usage in a particular ward. We report large declines in most hospitals under surveillance, but do not collect data on number of hospital admissions or other hospital denominator data, and are therefore unable to report if the declines are a true decrease in the risk of disease or if this is related to a shift in healthcare utilization (e.g., change in central line utilization, referral patterns, frequency of blood culture collection, etc). However, the majority of hospitals in our surveillance system demonstrated declines indicating a trend not isolated to a few institutions.</p>
      <p>This report describes significant declines in the incidence of candidemia bloodstream infections in two major U.S. locations over a 5 year period, and an increase in echinocandin resistant CG. Continued surveillance will be important to help understand factors contributing to these declines and to monitor for the emergence of resistant <italic>Candida</italic>.</p>
    </sec>
  </body>
  <back>
    <ack>
      <p><bold>Disclaimer:</bold>
<italic>The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention</italic>.</p>
      <p>We gratefully acknowledge the many individuals in the hospitals and laboratories in Baltimore and Atlanta for their help in identifying cases and isolates, and also thank the following individuals: Shelley Magill, MD, PhD, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention; Wendy Baughman, MSPH, Janine Scott, MPH, Jessica Reno, MPH, Lewis Perry, RN, MPH, Georgia Emerging Infections Program; Molly Hyde, MS, Helen Yoon, MS, Kim Holmes, RN, MS, Kathleen Shutt, MS, Maryland Emerging Infections Program; Gordana Derado, PhD, Kaitlin Benedict, MPH, Randy Kuykendall, MPH, Shirley McClinton, Joyce Peterson, Carol Bolden, Naureen Iqbal, Lalitha Gade, MS, and Mary Brandt, PhD, Mycotic Diseases Branch, Centers for Disease Control and Prevention.</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="pone.0120452.ref001">
        <label>1</label>
        <mixed-citation publication-type="other">US Department of Health and Human Services (USDHHS). National Action Plan to Reduce Healthcare-Associated Infections. Washington, DC. 2010. Available at <ext-link ext-link-type="uri" xlink:href="http://www.hhs.gov/ash/initiatives/hai/actionplan/index.html">http://www.hhs.gov/ash/initiatives/hai/actionplan/index.html</ext-link>. Accessed December 2, 2013.</mixed-citation>
      </ref>
      <ref id="pone.0120452.ref002">
        <label>2</label>
        <mixed-citation publication-type="journal"><name><surname>Lee</surname><given-names>GM</given-names></name>, <name><surname>Kleinman</surname><given-names>K</given-names></name>, <name><surname>Soumerai</surname><given-names>SB</given-names></name>, <name><surname>Tse</surname><given-names>A</given-names></name>, <name><surname>Cole</surname><given-names>D</given-names></name>, <name><surname>Fridkin</surname><given-names>SK</given-names></name>, <etal>et al</etal>
<article-title>Effect of nonpayment for preventable infections in U.S. hospitals</article-title>. <source>N Engl J Med</source>. <year>2012</year> Oct 11;<volume>367</volume>(<issue>15</issue>):<fpage>1428</fpage>–<lpage>37</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1056/NEJMsa1202419">10.1056/NEJMsa1202419</ext-link></comment><pub-id pub-id-type="pmid">23050526</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0120452.ref003">
        <label>3</label>
        <mixed-citation publication-type="journal"><name><surname>Ong</surname><given-names>A</given-names></name>, <name><surname>Dysert</surname><given-names>K</given-names></name>, <name><surname>Herbert</surname><given-names>C</given-names></name>, <name><surname>Laux</surname><given-names>L</given-names></name>, <name><surname>Granato</surname><given-names>J</given-names></name>, <name><surname>Crawford</surname><given-names>J</given-names></name>, <etal>et al</etal>
<article-title>Trends in central line–associated bloodstream infections in a trauma-surgical intensive care unit</article-title>. <source>Archives of Surgery</source>. <year>2011</year>;<volume>146</volume>(<issue>3</issue>):<fpage>302</fpage>–<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1001/archsurg.2011.9">10.1001/archsurg.2011.9</ext-link></comment>
<pub-id pub-id-type="pmid">21422361</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0120452.ref004">
        <label>4</label>
        <mixed-citation publication-type="journal"><name><surname>Dixon-Woods</surname><given-names>M</given-names></name>, <name><surname>Perencevich</surname><given-names>E</given-names></name>. <article-title>Commentary: When Counting Central Line Infections Counts</article-title>. <source>Infection Control and Hospital Epidemiology</source>. <year>2013</year>;<volume>34</volume>(<issue>6</issue>):<fpage>555</fpage>–<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1086/670630">10.1086/670630</ext-link></comment>
<pub-id pub-id-type="pmid">23651884</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0120452.ref005">
        <label>5</label>
        <mixed-citation publication-type="journal"><name><surname>Peasah</surname><given-names>S</given-names></name>, <name><surname>McKay</surname><given-names>N</given-names></name>, <name><surname>Harman</surname><given-names>J</given-names></name>, <name><surname>Al-Amin</surname><given-names>M</given-names></name>, <name><surname>Cook</surname><given-names>R</given-names></name>. <article-title>Medicare Non-Payment of Hospital-Acquired Infections: Infection Rates Three Years Post Implementation</article-title>. <source>Medicare &amp; Medicaid Research Review</source>. <year>2013</year>;<volume>3</volume>(<issue>3</issue>):<fpage>E1</fpage>–<lpage>E15</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0120452.ref006">
        <label>6</label>
        <mixed-citation publication-type="journal"><name><surname>Jha</surname><given-names>AK</given-names></name>, <name><surname>Joynt</surname><given-names>KE</given-names></name>, <name><surname>Orav</surname><given-names>EJ</given-names></name>, <name><surname>Epstein</surname><given-names>AM</given-names></name>. <article-title>The long-term effect of premier pay for performance on patient outcomes</article-title>. <source>N Engl J Med</source>. <year>2012</year> Apr 26;<volume>366</volume>(<issue>17</issue>):<fpage>1606</fpage>–<lpage>15</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1056/NEJMsa1112351">10.1056/NEJMsa1112351</ext-link></comment><pub-id pub-id-type="pmid">22455751</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0120452.ref007">
        <label>7</label>
        <mixed-citation publication-type="journal"><name><surname>Wisplinghoff</surname><given-names>H</given-names></name>, <name><surname>Bischoff</surname><given-names>T</given-names></name>, <name><surname>Tallent</surname><given-names>SM</given-names></name>, <name><surname>Seifert</surname><given-names>H</given-names></name>, <name><surname>Wenzel</surname><given-names>RP</given-names></name>, <name><surname>Edmond</surname><given-names>MB</given-names></name>. <article-title>Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study</article-title>. <source>Clin Infect Dis</source>. <year>2004</year> Aug 1;<volume>39</volume>(<issue>3</issue>):<fpage>309</fpage>–<lpage>17</lpage>. . Epub 2004/08/13. eng.<pub-id pub-id-type="pmid">15306996</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0120452.ref008">
        <label>8</label>
        <mixed-citation publication-type="journal"><name><surname>Zimlichman</surname><given-names>E</given-names></name>, <name><surname>Henderson</surname><given-names>D</given-names></name>, <name><surname>Tamir</surname><given-names>O</given-names></name>, <name><surname>Franz</surname><given-names>C</given-names></name>, <name><surname>Song</surname><given-names>P</given-names></name>, <name><surname>Yamin</surname><given-names>CK</given-names></name>, <etal>et al</etal>
<article-title>Health care–associated infections: A meta-analysis of costs and financial impact on the us health care system</article-title>. <source>JAMA Internal Medicine</source>. <year>2013</year>;<volume>173</volume>(<issue>22</issue>):<fpage>2039</fpage>–<lpage>46</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1001/jamainternmed.2013.9763">10.1001/jamainternmed.2013.9763</ext-link></comment>
<pub-id pub-id-type="pmid">23999949</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0120452.ref009">
        <label>9</label>
        <mixed-citation publication-type="journal"><name><surname>Cleveland</surname><given-names>AA</given-names></name>, <name><surname>Farley</surname><given-names>MM</given-names></name>, <name><surname>Harrison</surname><given-names>LH</given-names></name>, <name><surname>Stein</surname><given-names>B</given-names></name>, <name><surname>Hollick</surname><given-names>R</given-names></name>, <name><surname>Lockhart</surname><given-names>SR</given-names></name>, <etal>et al</etal>
<article-title>Changes in incidence and antifungal drug resistance in candidemia: results from population-based laboratory surveillance in Atlanta and Baltimore, 2008–2011</article-title>. <source>Clin Infect Dis</source>. <year>2012</year> Nov 15;<volume>55</volume>(<issue>10</issue>):<fpage>1352</fpage>–<lpage>61</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/cid/cis697">10.1093/cid/cis697</ext-link></comment><pub-id pub-id-type="pmid">22893576</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0120452.ref010">
        <label>10</label>
        <mixed-citation publication-type="journal"><name><surname>Schulman</surname><given-names>J</given-names></name>, <name><surname>Stricof</surname><given-names>R</given-names></name>, <name><surname>Stevens</surname><given-names>TP</given-names></name>, <name><surname>Horgan</surname><given-names>M</given-names></name>, <name><surname>Gase</surname><given-names>K</given-names></name>, <name><surname>Holzman</surname><given-names>IR</given-names></name>, <etal>et al</etal>
<article-title>Statewide NICU Central-Line-Associated Bloodstream Infection Rates Decline After Bundles and Checklists</article-title>. <source>Pediatrics</source>. 2008 March 1, <year>2011</year>;<volume>127</volume>(<issue>3</issue>):<fpage>436</fpage>–<lpage>44</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1542/peds.2010-2873">10.1542/peds.2010-2873</ext-link></comment>
<pub-id pub-id-type="pmid">21339265</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0120452.ref011">
        <label>11</label>
        <mixed-citation publication-type="journal"><name><surname>Pronovost</surname><given-names>P</given-names></name>, <name><surname>Needham</surname><given-names>D</given-names></name>, <name><surname>Berenholtz</surname><given-names>S</given-names></name>, <name><surname>Sinopoli</surname><given-names>D</given-names></name>, <name><surname>Chu</surname><given-names>H</given-names></name>, <name><surname>Cosgrove</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>An Intervention to Decrease Catheter-Related Bloodstream Infections in the ICU</article-title>. <source>New England Journal of Medicine</source>. <year>2006</year>;<volume>355</volume>(<issue>26</issue>):<fpage>2725</fpage>–<lpage>32</lpage>. <pub-id pub-id-type="pmid">17192537</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0120452.ref012">
        <label>12</label>
        <mixed-citation publication-type="journal"><name><surname>Marcos</surname><given-names>M</given-names></name>, <name><surname>Soriano</surname><given-names>A</given-names></name>, <name><surname>Iñurrieta</surname><given-names>A</given-names></name>, <name><surname>Martínez</surname><given-names>JA</given-names></name>, <name><surname>Romero</surname><given-names>A</given-names></name>, <name><surname>Cobos</surname><given-names>N</given-names></name>, <etal>et al</etal>
<article-title>Changing epidemiology of central venous catheter-related bloodstream infections: increasing prevalence of Gram-negative pathogens</article-title>. <source>Journal of Antimicrobial Chemotherapy</source>. 2011 September 1, <year>2011</year>;<volume>66</volume>(<issue>9</issue>):<fpage>2119</fpage>–<lpage>25</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/jac/dkr231">10.1093/jac/dkr231</ext-link></comment>
<pub-id pub-id-type="pmid">21665905</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0120452.ref013">
        <label>13</label>
        <mixed-citation publication-type="journal"><collab>Centers for Disease Control and Prevention (CDC)</collab>. <article-title>Vital signs: central line-associated blood stream infections—United States, 2001, 2008, and 2009</article-title>. <source>MMWR Morb Mortal Wkly Rep</source>. <year>2011</year> Mar 4;<volume>60</volume>(<issue>8</issue>):<fpage>243</fpage>–<lpage>8</lpage>. . Epub 2011/03/04. eng.<pub-id pub-id-type="pmid">21368740</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0120452.ref014">
        <label>14</label>
        <mixed-citation publication-type="journal"><name><surname>Fagan</surname><given-names>RP</given-names></name>, <name><surname>Edwards</surname><given-names>JR</given-names></name>, <name><surname>Park</surname><given-names>BJ</given-names></name>, <name><surname>Fridkin</surname><given-names>SK</given-names></name>, <name><surname>Magill</surname><given-names>SS</given-names></name>. <article-title>Incidence trends in pathogen-specific central line-associated bloodstream infections in US intensive care units, 1990–2010</article-title>. <source>Infect Control Hosp Epidemiol</source>. <year>2013</year> Sep;<volume>34</volume>(<issue>9</issue>):<fpage>893</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1086/671724">10.1086/671724</ext-link></comment><pub-id pub-id-type="pmid">23917902</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0120452.ref015">
        <label>15</label>
        <mixed-citation publication-type="journal"><name><surname>Kojic</surname><given-names>EM</given-names></name>, <name><surname>Darouiche</surname><given-names>RO</given-names></name>. <article-title>Candida infections of medical devices</article-title>. <source>Clin Microbiol Rev</source>. <year>2004</year> Apr;<volume>17</volume>(<issue>2</issue>):<fpage>255</fpage>–<lpage>67</lpage>. . Pubmed Central PMCID: 387407.<pub-id pub-id-type="pmid">15084500</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0120452.ref016">
        <label>16</label>
        <mixed-citation publication-type="journal"><name><surname>Reagan</surname><given-names>DR</given-names></name>, <name><surname>Pfaller</surname><given-names>MA</given-names></name>, <name><surname>Hollis</surname><given-names>RJ</given-names></name>, <name><surname>Wenzel</surname><given-names>RP</given-names></name>. <article-title>Characterization of the sequence of colonization and nosocomial candidemia using DNA fingerprinting and a DNA probe</article-title>. <source>J Clin Microbiol</source>. <year>1990</year> Dec;<volume>28</volume>(<issue>12</issue>):<fpage>2733</fpage>–<lpage>8</lpage>. . Pubmed Central PMCID: 268264.<pub-id pub-id-type="pmid">2177750</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0120452.ref017">
        <label>17</label>
        <mixed-citation publication-type="journal"><name><surname>Lockhart</surname><given-names>SR</given-names></name>, <name><surname>Iqbal</surname><given-names>N</given-names></name>, <name><surname>Cleveland</surname><given-names>AA</given-names></name>, <name><surname>Farley</surname><given-names>MM</given-names></name>, <name><surname>Harrison</surname><given-names>LH</given-names></name>, <name><surname>Bolden</surname><given-names>CB</given-names></name>, <etal>et al</etal>
<article-title>Species identification and antifungal susceptibility testing of Candida bloodstream isolates from population-based surveillance studies in two U.S. cities from 2008 to 2011</article-title>. <source>J Clin Microbiol</source>. <year>2012</year> Nov;<volume>50</volume>(<issue>11</issue>):<fpage>3435</fpage>–<lpage>42</lpage>. Pubmed Central PMCID: 3486211. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/JCM.01283-12">10.1128/JCM.01283-12</ext-link></comment><pub-id pub-id-type="pmid">22875889</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0120452.ref018">
        <label>18</label>
        <mixed-citation publication-type="book"><collab>Institute CaLS</collab>. <chapter-title>M27-A3 Reference method for broth dilution antifungal susceptibility testing of yeasts: Approved standard-third edition</chapter-title>
<publisher-name>Clinical Laboratory Standards Institute</publisher-name>, <publisher-loc>Wayne, PA</publisher-loc><year>2008</year>.</mixed-citation>
      </ref>
      <ref id="pone.0120452.ref019">
        <label>19</label>
        <mixed-citation publication-type="journal"><name><surname>Espinel-Ingroff</surname><given-names>A</given-names></name>, <name><surname>Arendrup</surname><given-names>MC</given-names></name>, <name><surname>Pfaller</surname><given-names>MA</given-names></name>, <name><surname>Bonfietti</surname><given-names>LX</given-names></name>, <name><surname>Bustamante</surname><given-names>B</given-names></name>, <name><surname>Canton</surname><given-names>E</given-names></name>, <etal>et al</etal>
<article-title>Interlaboratory variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST methods: should the clinical laboratory be testing this agent?</article-title>
<source>Antimicrob Agents Chemother</source>. <year>2013</year> Dec;<volume>57</volume>(<issue>12</issue>):<fpage>5836</fpage>–<lpage>42</lpage>. Pubmed Central PMCID: 3837874. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/AAC.01519-13">10.1128/AAC.01519-13</ext-link></comment><pub-id pub-id-type="pmid">24018263</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0120452.ref020">
        <label>20</label>
        <mixed-citation publication-type="journal"><name><surname>Pham</surname><given-names>CD</given-names></name>, <name><surname>Bolden</surname><given-names>CB</given-names></name>, <name><surname>Kuykendall</surname><given-names>RJ</given-names></name>, <name><surname>Lockhart</surname><given-names>SR</given-names></name>. <article-title>Development of a Luminex-Based Multiplex Assay for Detection of Mutations Conferring Resistance to Echinocandins in Candida glabrata</article-title>. <source>J Clin Microbiol</source>. <year>2014</year> Mar;<volume>52</volume>(<issue>3</issue>):<fpage>790</fpage>–<lpage>5</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/JCM.03378-13">10.1128/JCM.03378-13</ext-link></comment><pub-id pub-id-type="pmid">24353003</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0120452.ref021">
        <label>21</label>
        <mixed-citation publication-type="other">Maryland Vital Statistics Annual Report 2012. Division of Health Statistics, Maryland Department of Health and Mental Hygiene, 2012.</mixed-citation>
      </ref>
      <ref id="pone.0120452.ref022">
        <label>22</label>
        <mixed-citation publication-type="other">Estimates of the July 1, 2000-July 1, 2012, United States resident population from the Vintage 2012 postcensal series by year, county, age, sex, race, and Hispanic origin. 2012.</mixed-citation>
      </ref>
      <ref id="pone.0120452.ref023">
        <label>23</label>
        <mixed-citation publication-type="journal"><name><surname>Schulman</surname><given-names>J</given-names></name>, <name><surname>Stricof</surname><given-names>R</given-names></name>, <name><surname>Stevens</surname><given-names>TP</given-names></name>, <name><surname>Horgan</surname><given-names>M</given-names></name>, <name><surname>Gase</surname><given-names>K</given-names></name>, <name><surname>Holzman</surname><given-names>IR</given-names></name>, <etal>et al</etal>
<article-title>Statewide NICU Central-Line-Associated Bloodstream Infection Rates Decline After Bundles and Checklists</article-title>. <source>Pediatrics</source>. 2011 March 1, <year>2011</year>;<volume>127</volume>(<issue>3</issue>):<fpage>436</fpage>–<lpage>44</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1542/peds.2010-2873">10.1542/peds.2010-2873</ext-link></comment>
<pub-id pub-id-type="pmid">21339265</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0120452.ref024">
        <label>24</label>
        <mixed-citation publication-type="journal"><name><surname>Wise</surname><given-names>ME</given-names></name>, <name><surname>Douglas</surname><given-names>Scott II R</given-names></name>, <name><surname>Baggs</surname><given-names>JM</given-names></name>, <name><surname>Edwards</surname><given-names>JR</given-names></name>, <name><surname>Ellingson</surname><given-names>KD</given-names></name>, <name><surname>Fridkin</surname><given-names>SK</given-names></name>, <etal>et al</etal>
<article-title>National Estimates of Central Line–Associated Bloodstream Infections in Critical Care Patients</article-title>. <source>Infection Control and Hospital Epidemiology</source>. <year>2013</year>;<volume>34</volume>(<issue>6</issue>):<fpage>547</fpage>–<lpage>54</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1086/670629">10.1086/670629</ext-link></comment>
<pub-id pub-id-type="pmid">23651883</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0120452.ref025">
        <label>25</label>
        <mixed-citation publication-type="journal"><name><surname>Pfaller</surname><given-names>MA</given-names></name>, <name><surname>Castanheira</surname><given-names>M</given-names></name>, <name><surname>Lockhart</surname><given-names>SR</given-names></name>, <name><surname>Ahlquist</surname><given-names>AM</given-names></name>, <name><surname>Messer</surname><given-names>SA</given-names></name>, <name><surname>Jones</surname><given-names>RN</given-names></name>. <article-title>Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant bloodstream isolates of Candida glabrata</article-title>. <source>J Clin Microbiol</source>. <year>2012</year> Apr;<volume>50</volume>(<issue>4</issue>):<fpage>1199</fpage>–<lpage>203</lpage>. Pubmed Central PMCID: 3318516. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/JCM.06112-11">10.1128/JCM.06112-11</ext-link></comment><pub-id pub-id-type="pmid">22278842</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0120452.ref026">
        <label>26</label>
        <mixed-citation publication-type="journal"><name><surname>Alexander</surname><given-names>BD</given-names></name>, <name><surname>Johnson</surname><given-names>MD</given-names></name>, <name><surname>Pfeiffer</surname><given-names>CD</given-names></name>, <name><surname>Jimenez-Ortigosa</surname><given-names>C</given-names></name>, <name><surname>Catania</surname><given-names>J</given-names></name>, <name><surname>Booker</surname><given-names>R</given-names></name>, <etal>et al</etal>
<article-title>Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations</article-title>. <source>Clin Infect Dis</source>. <year>2013</year> Jun;<volume>56</volume>(<issue>12</issue>):<fpage>1724</fpage>–<lpage>32</lpage>. Pubmed Central PMCID: 3658363. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/cid/cit136">10.1093/cid/cit136</ext-link></comment><pub-id pub-id-type="pmid">23487382</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0120452.ref027">
        <label>27</label>
        <mixed-citation publication-type="journal"><name><surname>Pappas</surname><given-names>PG</given-names></name>, <name><surname>Kauffman</surname><given-names>CA</given-names></name>, <name><surname>Andes</surname><given-names>D</given-names></name>, <name><surname>Benjamin</surname><given-names>DK</given-names><suffix>Jr</suffix></name>, <name><surname>Calandra</surname><given-names>TF</given-names></name>, <name><surname>Edwards</surname><given-names>JE</given-names><suffix>Jr</suffix></name>, <etal>et al</etal>
<article-title>Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America</article-title>. <source>Clin Infect Dis</source>. <year>2009</year> Mar 1;<volume>48</volume>(<issue>5</issue>):<fpage>503</fpage>–<lpage>35</lpage>. Epub 2009/02/05. eng. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1086/596757">10.1086/596757</ext-link></comment><pub-id pub-id-type="pmid">19191635</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0120452.ref028">
        <label>28</label>
        <mixed-citation publication-type="journal"><name><surname>Pfaller</surname><given-names>MA</given-names></name>, <name><surname>Messer</surname><given-names>SA</given-names></name>, <name><surname>Woosley</surname><given-names>LN</given-names></name>, <name><surname>Jones</surname><given-names>RN</given-names></name>, <name><surname>Castanheira</surname><given-names>M</given-names></name>. <article-title>Echinocandin and triazole antifungal susceptibility profiles for clinical opportunistic yeast and mold isolates collected from 2010 to 2011: application of new CLSI clinical breakpoints and epidemiological cutoff values for characterization of geographic and temporal trends of antifungal resistance</article-title>. <source>J Clin Microbiol</source>. <year>2013</year> Aug;<volume>51</volume>(<issue>8</issue>):<fpage>2571</fpage>–<lpage>81</lpage>. Pubmed Central PMCID: 3719648. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/JCM.00308-13">10.1128/JCM.00308-13</ext-link></comment><pub-id pub-id-type="pmid">23720791</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0120452.ref029">
        <label>29</label>
        <mixed-citation publication-type="journal"><name><surname>Lewis</surname><given-names>JS</given-names><suffix>2nd</suffix></name>, <name><surname>Wiederhold</surname><given-names>NP</given-names></name>, <name><surname>Wickes</surname><given-names>BL</given-names></name>, <name><surname>Patterson</surname><given-names>TF</given-names></name>, <name><surname>Jorgensen</surname><given-names>JH</given-names></name>. <article-title>Rapid emergence of echinocandin resistance in Candida glabrata resulting in clinical and microbiologic failure</article-title>. <source>Antimicrob Agents Chemother</source>. <year>2013</year> Sep;<volume>57</volume>(<issue>9</issue>):<fpage>4559</fpage>–<lpage>61</lpage>. Pubmed Central PMCID: 3754289. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1128/AAC.01144-13">10.1128/AAC.01144-13</ext-link></comment><pub-id pub-id-type="pmid">23817368</pub-id></mixed-citation>
      </ref>
      <ref id="pone.0120452.ref030">
        <label>30</label>
        <mixed-citation publication-type="journal"><name><surname>Hammarskjold</surname><given-names>F</given-names></name>, <name><surname>Mernelius</surname><given-names>S</given-names></name>, <name><surname>Andersson</surname><given-names>RE</given-names></name>, <name><surname>Berg</surname><given-names>S</given-names></name>, <name><surname>Hanberger</surname><given-names>H</given-names></name>, <name><surname>Lofgren</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>Possible transmission of Candida albicans on an intensive care unit: genotype and temporal cluster analyses</article-title>. <source>J Hosp Infect</source>. <year>2013</year> Sep;<volume>85</volume>(<issue>1</issue>):<fpage>60</fpage>–<lpage>5</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.jhin.2013.06.002">10.1016/j.jhin.2013.06.002</ext-link></comment><pub-id pub-id-type="pmid">23927923</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>

